126
Participants
Start Date
March 24, 2014
Primary Completion Date
June 29, 2015
Study Completion Date
June 29, 2015
GSK2140944 Lyophile
GSK2140944 Lyophile (pale yellow to grayish yellow cake) containing 750 mg of GSK2140944 (as free base) per vial for IV infusion.
GSK2140944 Capsules
GSK2140944 500 mg capsules will be supplied as pink hard gelatin capsule with no external markings filled with slightly agglomerated pale yellow to grayish yellow powder.
GSK Investigational Site, Brooklyn
GSK Investigational Site, Albany
GSK Investigational Site, Pittsburgh
GSK Investigational Site, Augusta
GSK Investigational Site, Augusta
GSK Investigational Site, Miramar
GSK Investigational Site, West Palm Beach
GSK Investigational Site, Carriere
GSK Investigational Site, Hazard
GSK Investigational Site, Toledo
GSK Investigational Site, Lima
GSK Investigational Site, Council Bluffs
GSK Investigational Site, Minneapolis
GSK Investigational Site, Butte
GSK Investigational Site, Lincoln
GSK Investigational Site, Zachary
GSK Investigational Site, Houston
GSK Investigational Site, Houston
GSK Investigational Site, Channelview
GSK Investigational Site, Phoenix
GSK Investigational Site, Torrance
GSK Investigational Site, Sylmar
GSK Investigational Site, Chula Vista
GSK Investigational Site, La Mesa
GSK Investigational Site, Oceanside
GSK Investigational Site, Las Vegas
GSK Investigational Site, Anaheim
GSK Investigational Site, Jackson
GSK Investigational Site, Belleville
GSK Investigational Site, Neptune City
Lead Sponsor
GlaxoSmithKline
INDUSTRY